{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:08:05Z","timestamp":1755223685756,"version":"3.43.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pleomorphic giant cell adenocarcinoma (PGCA) of the prostate is a rare, aggressive variant characterized by multinucleated giant cells, sarcomatoid features, and resistance to conventional therapies. Despite its recognition in the WHO 2016 guidelines, the molecular drivers and clinicopathological correlates of PGCA remain poorly characterized. This study presents the first integrative clinicogenomic profiling of PGCA, revealing a novel prognostic gene signature with direct implications for diagnosis and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted comprehensive clinicopathological and genomic analyses of a treatment-refractory PGCA case using histology, immunohistochemistry (IHC), whole-exome sequencing (WES), clonal evolution modeling, and multicohort validation. IHC assessed key prostate cancer markers (AR, AMACR, KLK3, PTEN, NKX3-1, VIM), while WES compared somatic alterations in PGCA, adjacent adenocarcinoma, and stromal tissue. Public datasets (prostate_dkfz_2018, prad_tcga, prad_mcspc_mskcc_2020) were used for external validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PGCA displayed profound pleomorphism, necrosis, and complete loss of luminal markers (AR\/AMACR\/KLK3), along with strong vimentin (VIM) expression, consistent with epithelial\u2013mesenchymal transition. WES revealed PGCA-specific mutations enriched in cell-cycle and inflammatory response pathways, distinct from metabolic alterations in the adjacent adenocarcinoma. Clonal evolution analysis showed divergent progression from a shared ancestral clone. Importantly, mutations in ADAMTS7, CDH1, DRD5, MGAT5, and TP53 emerged as a robust five-gene signature predictive of biochemical recurrence, metastasis, and poor survival, validated across multiple independent cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study provides the first molecular roadmap of prostatic PGCA to date, establishing a novel five-gene prognostic signature and revealing fundamental insights into its pathogenesis through divergent evolution from conventional adenocarcinoma. These insights offer new opportunities for precise diagnosis, prognostic stratification, and targeted therapeutic strategies for this lethal prostate cancer variant.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1609340","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:11:28Z","timestamp":1754979088000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoshi","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaipeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jizhou","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianlin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000002285","article-title":"Inflammatory giant cell carcinoma of the lung: clinicopathologic, immunohistochemical, and next-generation sequencing study of 14 cases","volume":"48","author":"Suster","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-03858-w","article-title":"Giant cell carcinoma of the urinary bladder: Clinicopathologic analysis and oncological outcomes","volume":"485","author":"Portugal-Gaspar","year":"2024","journal-title":"Virchows Arch"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.3390\/diagnostics13182941","article-title":"An anaplastic thyroid carcinoma of the giant-cell type from a mediastinal ectopic thyroid gland","volume":"13","author":"Nguyen","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-022-01596-8","article-title":"Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells","volume":"21","author":"Wang","year":"2022","journal-title":"Mol Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5858\/2005-129-0683-pgccot","article-title":"Pleomorphic giant cell carcinoma of the prostate","volume":"129","author":"Lopez-Beltran","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151719","article-title":"Pleomorphic giant cell carcinoma of prostate: Rare tumor with unique clinicopathological, immunohistochemical, and molecular features","volume":"52","author":"El-Zaatari","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001112","article-title":"Prostatic adenocarcinoma with focal pleomorphic giant cell features: a series of 30 cases","volume":"42","author":"Alharbi","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13000-016-0478-2","article-title":"Grading of prostatic adenocarcinoma: current state and prognostic implications","volume":"11","author":"Gordetsky","year":"2016","journal-title":"Diagn Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.11.032","article-title":"Application of a prognostic gleason grade grouping system to assess distant prostate cancer outcomes","volume":"71","author":"Leapman","year":"2017","journal-title":"Eur Urol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00428-022-03481-7","article-title":"Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes","volume":"482","author":"Bil\u00e9-Silva","year":"2023","journal-title":"Virchows Arch"},{"key":"B12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus Ipilimumab for metastatic castration-resistant prostate cancer: preliminary analysis of patients in the CheckMate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/jco.19.01638","article-title":"Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)70189-5","article-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","volume":"15","author":"Kwon","year":"2014","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3892\/mi.2023.120","article-title":"Pleomorphic giant cell carcinoma of the prostate: a case report and mini\u2212review of the literature","volume":"3","author":"Fakhralddin","year":"2023","journal-title":"Med Int (Lond)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2134-y","article-title":"HOXB13 a useful marker in pleomorphic giant cell adenocarcinoma of the prostate: a case report and review of the literature","volume":"471","author":"Larnaudie","year":"2017","journal-title":"Virchows Arch"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/his.14205","article-title":"Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases","volume":"77","author":"Alhamar","year":"2020","journal-title":"Histopathology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/his.13806","article-title":"DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features","volume":"74","author":"Lotan","year":"2019","journal-title":"Histopathology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/cells8091065","article-title":"Total DNA methylation changes reflect random oxidative dna damage in gliomas","volume":"8","author":"Barciszewska","year":"2019","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/ijo.2023.5522","article-title":"New insights into lipid metabolism and prostate cancer (Review)","volume":"62","author":"Zhang","year":"2023","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/ijms17081208","article-title":"One-carbon metabolism in prostate cancer: the role of androgen signaling","volume":"17","author":"Corbin","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1392","article-title":"Fatty acid synthesis in prostate cancer: vulnerability or epiphenomenon","volume":"81","author":"Sena","year":"2021","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers4041252","article-title":"Emerging roles of ADAMTSs in angiogenesis and cancer","volume":"4","author":"Kumar","year":"2012","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81279-9","article-title":"Cell adhesion: the molecular basis of tissue architecture and morphogenesis","volume":"84","author":"Gumbiner","year":"1996","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J Cell Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1328347","article-title":"Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death","volume":"13","author":"Leng","year":"2017","journal-title":"Autophagy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.178804","article-title":"N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance","volume":"9","author":"Hollander","year":"2024","journal-title":"JCI Insight"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-024-01259-9","article-title":"Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control","volume":"32","author":"Janic","year":"2025","journal-title":"Cell Death Differ"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0165-1","article-title":"Genome doubling shapes the evolution and prognosis of advanced cancers","volume":"50","author":"Bielski","year":"2018","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000209841.77595.4b","article-title":"Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases","volume":"30","author":"Parwani","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724781","article-title":"Stress-induced polyploid giant cancer cells: unique way of formation and non-negligible characteristics","volume":"11","author":"Song","year":"2021","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/903542","article-title":"Number of polyploid giant cancer cells and expression of EZH2 are associated with VM formation and tumor grade in human ovarian tumor","volume":"2014","author":"Zhang","year":"2014","journal-title":"BioMed Res Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.09.005","article-title":"The \u201clife code\u201d: a theory that unifies the human life cycle and the origin of human tumors","volume":"60","author":"Liu","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26021","article-title":"Formation of solid tumors by a single multinucleated cancer cell","volume":"117","author":"Weihua","year":"2011","journal-title":"Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.01.037","article-title":"Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo","volume":"333","author":"Zhang","year":"2013","journal-title":"Cancer Lett"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7150\/jca.17012","article-title":"Daughter cells and erythroid cells budding from PGCCs and their clinicopathological significances in colorectal cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"J Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.12.006","article-title":"Vimentin and cytokeratin: Good alone, bad together","volume":"86","author":"Kuburich","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107731","article-title":"Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest","volume":"152","author":"Zhou","year":"2024","journal-title":"Bioorg Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026104","article-title":"The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1208","article-title":"Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer","volume":"3","author":"Siegel","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12032-019-1303-z","article-title":"EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment","volume":"36","author":"Wang","year":"2019","journal-title":"Med Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00182","article-title":"Molecular mechanisms by which S100A4 regulates the migration and invasion of PGCCs with their daughter cells in human colorectal cancer","volume":"10","author":"Fei","year":"2020","journal-title":"Front Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","article-title":"Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21873\/cgp.20484","article-title":"Whole-genome sequencing analysis of bile tract cancer reveals mutation characteristics and potential biomarkers","volume":"22","author":"Kokuryo","year":"2025","journal-title":"Cancer Genomics Proteomics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"22342","DOI":"10.1038\/s41598-024-73324-9","article-title":"Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9636","article-title":"Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations","volume":"7","author":"Yao","year":"2016","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family","volume":"16","author":"Kelwick","year":"2015","journal-title":"Genome Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E16-01-0058","article-title":"Roles for E-cadherin cell surface regulation in cancer","volume":"27","author":"Petrova","year":"2016","journal-title":"Mol Biol Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s0968-0004(98)01343-7","article-title":"The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene","volume":"24","author":"Christofori","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90143-m","article-title":"Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role","volume":"66","author":"Vleminckx","year":"1991","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000001281","article-title":"Genomic and immune microenvironment features influencing chemoimmunotherapy response in gastric cancer with peritoneal metastasis: a retrospective cohort study","volume":"110","author":"Yu","year":"2024","journal-title":"Int J Surg"},{"key":"B58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12885-021-07837-1","article-title":"Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer","volume":"21","author":"Tan","year":"2021","journal-title":"BMC Cancer"},{"key":"B59","article-title":"DNA microarray reveals different pathways responding to paclitaxel and docetaxel in non-small cell lung cancer cell line","volume":"6","author":"Che","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2020.5829","article-title":"Hypermethylation of DRD5 promoter is a biomarker across 12 cancer types","volume":"39","author":"Bai","year":"2020","journal-title":"DNA Cell Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.909324","article-title":"Immunogenomic characteristics of cell-death-associated genes with prognostic implications in bladder cancer","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-21-4084","article-title":"Dopamine signaling promotes tissue-resident memory differentiation of CD8+ T cells and antitumor immunity","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s13402-023-00770-4","article-title":"Aberrant N-glycosylation in cancer: MGAT5 and \u03b21,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression","volume":"46","author":"de-Souza-Ferreira","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101666","article-title":"N-acetylglucosaminyltransferase-V requires a specific noncatalytic luminal domain for its activity toward glycoprotein substrates","volume":"298","author":"Osuka","year":"2022","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/73163","article-title":"Suppression of tumor growth and metastasis in Mgat5-deficient mice","volume":"6","author":"Granovsky","year":"2000","journal-title":"Nat Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3158","article-title":"Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1038\/s41467-024-47069-y","article-title":"Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade","volume":"15","author":"Nie","year":"2024","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1609340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:11:28Z","timestamp":1754979088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1609340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2025.1609340"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1609340","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"article-number":"1609340"}}